HARMONY BIOSCIENCES HOLDINGS, INC. Accounts Payable
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) had Accounts Payable of $21.68 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-04
- 2026-06-30: Accounts Payable, Current $21.68M.
- 2026-03-31: Accounts Payable, Current $28.60M.
- 2025-12-31: Accounts Payable, Current $17.69M.
- 2025-09-30: Accounts Payable, Current $26.34M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $21.68M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $28.60M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $17.69M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $26.34M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $28.30M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $17.46M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $13.74M 10-K · filed 2026-02-24 |
| 2024-09-30 | $10.53M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $22.68M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $15.14M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $17.73M 10-K · filed 2025-02-25 |
| 2023-09-30 | $6.54M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $6.56M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $6.41M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $3.79M 10-K · filed 2024-02-22 |
| 2022-09-30 | $10.05M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $6.66M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $6.90M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $1.00M 10-K · filed 2023-02-21 |
| 2021-09-30 | $4.18M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.01M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $4.39M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.56M 10-K · filed 2022-02-28 |
| 2020-09-30 | $9.35M 10-Q · filed 2020-11-12 |
| 2019-12-31 | $6.36M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |